Aquestive Therapeutics (AQST) Receivables (2017 - 2026)
Aquestive Therapeutics' Receivables was $5.25 million in Q3 2026, down 62.8% from $14.13 million a year earlier and down 43.7% from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Receivables (2017 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Aquestive Therapeutics came in at $17.76 million, up 80.9% from FY2024.
- Receivables shows a five-year compound annual growth rate of 20.6% (FY2020 to FY2025).
- In earlier years, Receivables was $9.82 million in FY2024 (-13.8%), $11.39 million in FY2023 (+142.0%), $4.7 million in FY2022 (-61.2%) and $12.12 million in FY2021 (+74.3%).
- The Q3 2026 figure marks the lowest quarterly Receivables since Q4 2022.
- Compared with a year earlier, Receivables has declined for three straight quarters, with growth averaging 7.1% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q4 2023 (growth of 142.0%); the worst was Q3 2026 (a decline of 62.8%).
- Per Business Quant data, AQST's Receivables in the three quarters before Q3 2026 was $9.33 million (Q2 2026), $6.87 million (Q1 2026) and $17.76 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn | 5.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.25 Mn |
| Jun 30, 2026 | 9.33 Mn |
| Mar 31, 2026 | 6.87 Mn |
| Dec 31, 2025 | 17.76 Mn |
| Sep 30, 2025 | 14.13 Mn |
| Jun 30, 2025 | 14.07 Mn |
| Mar 31, 2025 | 12.66 Mn |
| Dec 31, 2024 | 9.82 Mn |
| Sep 30, 2024 | 11.68 Mn |
| Jun 30, 2024 | 7.67 Mn |
| Mar 31, 2024 | 9.96 Mn |
| Dec 31, 2023 | 11.39 Mn |
| Sep 30, 2023 | 8.55 Mn |
| Jun 30, 2023 | 10.10 Mn |
| Mar 31, 2023 | 7.55 Mn |
| Dec 31, 2022 | 4.70 Mn |
| Sep 30, 2022 | 10.74 Mn |
| Jun 30, 2022 | 19.17 Mn |
| Mar 31, 2022 | 19.90 Mn |
| Dec 31, 2021 | 12.12 Mn |
API Access
Aquestive Therapeutics Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();